Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.
Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.
No spam. Unsubscribe anytime. Clinical rigor, always.
Deep dives into peptide science — evidence-graded, honestly reported
You're spending $200–500/month on biological software and tracking it in a Notes app. The compounds aren't the problem. The total absence of protocol discipline is.
Peptide access exploded in 2026. Protocol discipline didn't follow. Most users are dosing from Reddit consensus, ignoring half-lives, missing timing windows, and running zero safety baselines. This article maps the specific failure modes, the insulin trap, the NO floor, the receptor ceiling, the sedentary trap, and what precision tracking actually looks like by comparison.
Detailed compound profiles with mechanisms, safety data, and dosing protocols
An ACTH-derived heptapeptide that upregulates BDNF, modulates the Default Mode Network, and delivers 20-24 hours of neuroprotection per dose — without a single hormonal side effect.
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) engineered from the ACTH(4-10) fragment. It upregulates Brain-Derived Neurotrophic Factor, inhibits enkephalinase, and suppresses neuroinflammation — delivering cognitive enhancement, stroke recovery support, and neuroprotection through a single intranasal molecule.
35+
Articles
18
Categories